Literature DB >> 6192722

Differential diagnosis of chordoma, chondroid, and ependymal tumors as aided by anti-intermediate filament antibodies.

M Miettinen, V P Lehto, D Dahl, I Virtanen.   

Abstract

Six chordomas, nine chondrosarcomas, and three myxopapillary ependymomas of the filum terminale were evaluated immunohistochemically for the expression of intermediate filament proteins by the use of monospecific antibodies against intermediate filament proteins of keratin, vimentin, and glial fibrillary acidic protein (GFAP) type. All chordomas were positive for keratin but negative for GFAP, whereas chondrosarcomas and ependymomas were negative for keratin. Chondrosarcomas showed strong vimentin positivity, whereas ependymomas were positive for GFAP. Chordomas showed desmosomelike junctions by electron microscopy, whereas chondrosarcomas of different types showed no junctions or only primitive ones. By electron microscopy chordomas often showed prominent intermediate filaments also associated with desmosomes, and poorly differentiated chondrosarcomas also showed prominent intermediate filaments. Keratin positivity of chordomas suggests their epithelial nature, while vimentin positivity of chondrosarcomas is in line with their mesenchymal derivation. The results also show that antibodies against different intermediate filament proteins can be applied as diagnostic aids in making the distinction between chordomas, chondroid tumors, and ependymal tumors.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6192722      PMCID: PMC1916268     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  34 in total

1.  The role of glial fibrillary acidic protein in the diagnosis of central nervous system tumors.

Authors:  J H Deck; L F Eng; J Bigbee; S M Woodcock
Journal:  Acta Neuropathol       Date:  1978-06-30       Impact factor: 17.088

2.  Differences among 100-A filamentilament subunits from different cell types.

Authors:  G S Bennett; S A Fellini; J M Croop; J J Otto; J Bryan; H Holtzer
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

3.  Different intermediate-sized filaments distinguished by immunofluorescence microscopy.

Authors:  W W Franke; E Schmid; M Osborn; K Weber
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

4.  Chondrosarcoma: a light and electron microscopic study.

Authors:  R A Erlandson; A G Huvos
Journal:  Cancer       Date:  1974-11       Impact factor: 6.860

5.  Extraskeletal myxoid chondrosarcoma. An analysis of 34 cases.

Authors:  F M Enzinger; M Shiraki
Journal:  Hum Pathol       Date:  1972-09       Impact factor: 3.466

6.  Chordoid sarcoma.

Authors:  R F Martin; P J Melnick; N E Warner; R Terry; W K Bullock; C P Schwinn
Journal:  Am J Clin Pathol       Date:  1973-05       Impact factor: 2.493

7.  The ultrastructure of chordoma.

Authors:  C E Peña; B L Horvat; E R Fisher
Journal:  Am J Clin Pathol       Date:  1970-04       Impact factor: 2.493

8.  Immunohistochemical analysis of formaldehyde- and trypsin- or pepsin-treated material.

Authors:  M Brozman
Journal:  Acta Histochem       Date:  1978       Impact factor: 2.479

9.  Ultrastructure of the so-called "chordoid sarcoma". Evidence supporting cartilagenous differentiation.

Authors:  S W Weiss
Journal:  Cancer       Date:  1976-01       Impact factor: 6.860

10.  Glial fibrillary acidic protein in ependymomas and other brain tumors. Distribution, diagnostic criteria, and relation to formation of processes.

Authors:  P E Duffy; L Graf; Y Y Huang; M M Rapport
Journal:  J Neurol Sci       Date:  1979-02       Impact factor: 3.181

View more
  15 in total

1.  Chondrosarcomas of the petrous apex.

Authors:  R Charachon; B Gratacap; J P Lavieille
Journal:  Skull Base Surg       Date:  1992

2.  Tissue polypeptide antigen staining of the chordoma and notochordal remnants.

Authors:  P C Burger; M Makek; P Kleihues
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

3.  Derivation and characterization of an extra-axial chordoma cell line (EACH-1) from a scapular tumor.

Authors:  Amalia M DeComas; Patrice Penfornis; Michael R Harris; Mark S Meyer; Radhika R Pochampally
Journal:  J Bone Joint Surg Am       Date:  2010-05       Impact factor: 5.284

4.  Case report 357: chordoma of the fourth lumbar vertebra metastasizing to the thoracic spine and ribs.

Authors:  I F Abdelwahab; P F O'Leary; G C Steiner; A Zwass
Journal:  Skeletal Radiol       Date:  1986       Impact factor: 2.199

5.  Glial fibrillary acidic protein and cartilage.

Authors:  C L Dolman
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

6.  Immunohistochemical study of ependymal neoplasms: histological subtypes and glial and epithelial characteristics.

Authors:  Y Kaneko; I Takeshita; T Matsushima; T Iwaki; T Tashima; M Fukui
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

7.  Parachordoma: an ultrastructural and immunohistochemical study.

Authors:  T Ishida; H Oda; T Oka; T Imamura; R Machinami
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

8.  A marker for primary choroid plexus neoplasms.

Authors:  J Herbert; T Cavallaro; A J Dwork
Journal:  Am J Pathol       Date:  1990-06       Impact factor: 4.307

9.  Brachyury, SOX-9, and podoplanin, new markers in the skull base chordoma vs chondrosarcoma differential: a tissue microarray-based comparative analysis.

Authors:  Gerard J Oakley; Kim Fuhrer; Raja R Seethala
Journal:  Mod Pathol       Date:  2008-09-26       Impact factor: 7.842

10.  Glial fibrillary acidic protein immunoreactivity in human respiratory tract cartilages and pulmonary chondromatous hamartomas.

Authors:  G Viale; C Doglioni; P Dell'Orto; G Zanetti; P Iuzzolino; L Bontempini; G Coggi
Journal:  Am J Pathol       Date:  1988-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.